Interestingly, experimental data show that FGF-23 may, via specific myocardial FGF receptor activation, act as a mediator for cardiac hypertrophy, cardiac fibrosis, and dysfunction [8]. The gene discussed is FGF23; the disease is cardiac hypertrophy.